Citations

Citations to this article as recorded by  

• Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non–Small-Cell Lung Cancer: Results From the CANOPY-1 Trial
  Daniel S.W. Tan, Enriqueta Felip, Gilberto de Castro, Benjamin J. Solomon, Alastair Greystoke, Byoung Chul Cho, Manuel Cobo, Tae Min Kim, Sandip Ganguly, Enric Carcereny, Luis Paz-Ares, Jaafar Bennouna, Marina Chiara Garassino, Michael Schenker, Sang-We K
  Journal of Clinical Oncology.2024; 42(2): 192.     CrossRef
• Canakinumab in combination with docetaxel compared with docetaxel alone for the treatment of advanced non-small cell lung cancer following platinum-based doublet chemotherapy and immunotherapy (CANOPY-2): A multicenter, randomized, double-blind, phase 3 t
  Luis Paz-Ares, Yasushi Goto, Darren Wan-Teck Lim, Balazs Halmos, Byoung Chul Cho, Manuel Cobo, José Luis González Larriba, Caicun Zhou, Ingel Demedts, Akin Atmaca, Sofia Baka, Bijoyesh Mookerjee, Socorro Portella, Zewen Zhu, Jincheng Wu, David Demanse, Bh
  Lung Cancer.2024; 189: 107451.     CrossRef
• Targeting Notch-Driven Cytokine Secretion: Novel Therapies for Triple Negative Breast Cancer
  Wanda Marini, Brooke E. Wilson, Michael Reedijk
  DNA and Cell Biology.2023; 42(2): 73.     CrossRef
• IL-1β is involved in docetaxel chemoresistance by regulating the formation of polyploid giant cancer cells in non-small cell lung cancer
  Song Zhao, Sining Xing, Lili Wang, Mingyue Ouyang, Shuo Liu, Lingyan Sun, Huiying Yu
  Scientific Reports.2023;[Epub]     CrossRef
• Prognostic Implications of Pyroptosis-Related Gene Signatures in Lung Squamous Cell Carcinoma
  Tingting Li, Huanqing Liu, Chunsheng Dong, Jun Lyu
  Frontiers in Pharmacology.2022;[Epub]     CrossRef
• Recruitment and activation of type 3 innate lymphoid cells promote antitumor immune responses
  Mélanie Bruchard, Mannon Geindreau, Anaïs Perrichet, Caroline Truntzer, Elise Ballot, Romain Boidot, Cindy Racoeur, Emilie Barsac, Fanny Chalmin, Christophe Hibos, Thomas Baranek, Christophe Paget, Bernhard Ryffel, Cédric Rébé, Catherine Paul, Frédérique
  Nature Immunology.2022; 23(2): 262.     CrossRef
• Targeting interleukin-1β and inflammation in lung cancer
  Jun Zhang, Nirmal Veeramachaneni
  Biomarker Research.2022;[Epub]     CrossRef
• Immunohistochemical Detection of Pro-Inflammatory and Anti-Inflammatory Interleukins in the Lungs of Sheep with Jaagsiekte
  Emin KARAKURT, Enver BEYTUT, Serpil DAĞ, Hilmi NUHOĞLU, Ayfer YILDIZ, Emre KURTBAŞ
  Turkish Journal of Veterinary Research.2022; 6(1): 9.     CrossRef
• Implications of Hyperoxia over the Tumor Microenvironment: An Overview Highlighting the Importance of the Immune System
  Ana Belén Herrera-Campos, Esteban Zamudio-Martinez, Daniel Delgado-Bellido, Mónica Fernández-Cortés, Luis M. Montuenga, F. Javier Oliver, Angel Garcia-Diaz
  Cancers.2022; 14(11): 2740.     CrossRef
• Repositioning canakinumab for non-small cell lung cancer—important lessons for drug repurposing in oncology
  Mark P. Lythgoe, Vinay Prasad
  British Journal of Cancer.2022; 127(5): 785.     CrossRef
• Promotion of angiogenesis in vitro by Astragalus polysaccharide via activation of TLR4 signaling pathway
  Huiqing Qiu, Liyan Zhang, Xinqi He, Yusen Wei, Miaoran Wang, Bin Ma, Dailun Hu, Zhongli Shi
  Journal of Food Biochemistry.2022;[Epub]     CrossRef
• B Cell Receptor Signaling Pathway Mutation as Prognosis Predictor of Immune Checkpoint Inhibitors in Lung Adenocarcinoma by Bioinformatic Analysis
  Anqi Lin, Jianbo Fang, Quan Cheng, Zaoqu Liu, Peng Luo, Jian Zhang
  Journal of Inflammation Research.2022; Volume 15: 5541.     CrossRef
• Biological Rationale for Peripheral Blood Cell–Derived Inflammatory Indices and Related Prognostic Scores in Patients with Advanced Non-Small-Cell Lung Cancer
  Giuseppe Luigi Banna, Alex Friedlaender, Marco Tagliamento, Veronica Mollica, Alessio Cortellini, Sara Elena Rebuzzi, Arsela Prelaj, Abdul Rafeh Naqash, Edouard Auclin, Lucia Garetto, Laura Mezquita, Alfredo Addeo
  Current Oncology Reports.2022; 24(12): 1851.     CrossRef
• IL-1β enhances cell viability and decreases 5-FU sensitivity in novel colon cancer cell lines derived from African American patients
  Marzia Spagnardi, Jenny Paredes, Jovanny Zabaleta, Jone Garai, Tiana Reyes, Laura A. Martello, Jennie L. Williams
  Frontiers in Oncology.2022;[Epub]     CrossRef
• Immune Resistance in Lung Adenocarcinoma
  Magda Spella, Georgios T. Stathopoulos
  Cancers.2021; 13(3): 384.     CrossRef
• The Role of Tumor Inflammatory Microenvironment in Lung Cancer
  Zhaofeng Tan, Haibin Xue, Yuli Sun, Chuanlong Zhang, Yonglei Song, Yuanfu Qi
  Frontiers in Pharmacology.2021;[Epub]     CrossRef
• Interleukin-1β and Cancer
  Cédric Rébé, François Ghiringhelli
  Cancers.2020; 12(7): 1791.     CrossRef
• Immune Cells Combined With NLRP3 Inflammasome Inhibitor Exert Better Antitumor Effect on Pancreatic Ductal Adenocarcinoma
  Hailiang Liu, Yong Xu, Kai Liang, Rong Liu
  Frontiers in Oncology.2020;[Epub]     CrossRef
• Identification of a novel subpopulation of Caspase-4 positive non-small cell lung Cancer patients
  Michela Terlizzi, Chiara Colarusso, Ilaria De Rosa, Pasquale Somma, Carlo Curcio, Rita P. Aquino, Luigi Panico, Rosario Salvi, Federica Zito Marino, Gerardo Botti, Aldo Pinto, Rosalinda Sorrentino
  Journal of Experimental & Clinical Cancer Research.2020;[Epub]     CrossRef
• A review of canakinumab and its therapeutic potential for non-small cell lung cancer
  Kara M. Schenk, Joshua E. Reuss, Karin Choquette, Alexander I. Spira
  Anti-Cancer Drugs.2019; 30(9): 879.     CrossRef
• Listeria monocytogenes Cancer Vaccines: Bridging Innate and Adaptive Immunity
  Zachary T. Morrow, Zachary M. Powers, John-Demian Sauer
  Current Clinical Microbiology Reports.2019; 6(4): 213.     CrossRef
• Cell Death, Inflammation, Tumor Burden, and Proliferation Blood Biomarkers Predict Lung Cancer Radiotherapy Response and Correlate With Tumor Volume and Proliferation Imaging
  Ahmed Salem, Hitesh Mistry, Alison Backen, Clare Hodgson, Pek Koh, Emma Dean, Lynsey Priest, Kate Haslett, Ioannis Trigonis, Alan Jackson, Marie-Claude Asselin, Caroline Dive, Andrew Renehan, Corinne Faivre-Finn, Fiona Blackhall
  Clinical Lung Cancer.2018; 19(3): 239.     CrossRef
• Elucidating the Role of CD84 and AHR in Modulation of LPS-Induced Cytokines Production by Cruciferous Vegetable-Derived Compounds Indole-3-Carbinol and 3,3′-Diindolylmethane
  Thomas Wang, Quynhchi Pham, Young Kim
  International Journal of Molecular Sciences.2018; 19(2): 339.     CrossRef
• IL‐1β promotes the nuclear translocaiton of S100A4 protein in gastric cancer cells MGC803 and the cell's stem‐like properties through PI3K pathway
  Aiwen Yu, Yu Wang, Yue Bian, Lisha Chen, Junfu Guo, Wei Shen, Danqi Chen, Shanshan Liu, Xiuju Sun
  Journal of Cellular Biochemistry.2018; 119(10): 8163.     CrossRef
• SNAI2 and TWIST1 in lymph node progression in early stages of NSCLC patients
  Camille Emprou, Pauline Le Van Quyen, Jérémie Jégu, Nathalie Prim, Noëlle Weingertner, Eric Guérin, Erwan Pencreach, Michèle Legrain, Anne‐Claire Voegeli, Charlotte Leduc, Bertrand Mennecier, Pierre‐Emmanuel Falcoz, Anne Olland, Nicolas Santelmo, Elisabet
  Cancer Medicine.2018; 7(7): 3278.     CrossRef
• RNA-Sequencing data supports the existence of novel VEGFA splicing events but not of VEGFAxxxb isoforms
  Stephen Bridgett, Margaret Dellett, David A. Simpson
  Scientific Reports.2017;[Epub]     CrossRef
• Cordycepin inhibits LPS-induced inflammatory responses by modulating NOD-Like Receptor Protein 3 inflammasome activation
  Jing Yang, Yun-zhou Li, Phillip B. Hylemon, Lu-yong Zhang, Hui-ping Zhou
  Biomedicine & Pharmacotherapy.2017; 95: 1777.     CrossRef
• Syndrome of Inappropriate Antidiuretic Hormone Secretion: A Poor Prognosis in Small-cell Lung Cancer
  Xu Wang, Min Liu, Lei Zhang, Kewei Ma
  Archives of Medical Research.2016; 47(1): 19.     CrossRef
• Prediction of survival and tumor recurrence in patients undergoing surgery for pancreatic neuroendocrine neoplasms
  Alexander Kaltenborn, Svenja Matzke, Moritz Kleine, Till Krech, Wolf Ramackers, Florian W. R. Vondran, Jürgen Klempnauer, Hüseyin Bektas, Harald Schrem
  Journal of Surgical Oncology.2016; 113(2): 194.     CrossRef
• Association of CT perfusion imaging with plasma levels of TGF-β1 and VEGF in patients with NSCLC
  Da-Wei Li, Bao-Zhong Wu, Yu-Sen Shi, Zhi-Qun Li, Xu-Dong Liu, Xiao-Hua Li
  Asian Pacific Journal of Tropical Medicine.2016; 9(2): 177.     CrossRef
• Promotion of a cancer-like phenotype, through chronic exposure to inflammatory cytokines and hypoxia in a bronchial epithelial cell line model
  Anne-Marie Baird, Steven G. Gray, Derek J. Richard, Kenneth J. O’Byrne
  Scientific Reports.2016;[Epub]     CrossRef
• Dysregulation of TGFβ1 Activity in Cancer and Its Influence on the Quality of Anti-Tumor Immunity
  Kristian Hargadon
  Journal of Clinical Medicine.2016; 5(9): 76.     CrossRef
• Associations of Circulating Cytokines and Chemokines With Cancer Mortality in Men With Rheumatoid Arthritis
  Bryant R. England, Jeremy Sokolove, William H. Robinson, Geoffrey M. Thiele, Apar K. Ganti, Harlan Sayles, Kaleb Michaud, Liron Caplan, Lisa A. Davis, Grant W. Cannon, Brian Sauer, Namrata Singh, E. Blair Solow, Andreas M. Reimold, Gail S. Kerr, Pascale S
  Arthritis & Rheumatology.2016; 68(10): 2394.     CrossRef
• The inflammasome: an emerging therapeutic oncotarget for cancer prevention
  Wang Zhiyu, Neng Wang, Qi Wang, Cheng Peng, Jin Zhang, Pengxi Liu, Aihua Ou, Shaowen Zhong, Mario D. Cordero, Yi Lin
  Oncotarget.2016; 7(31): 50766.     CrossRef
• Elevated chronic inflammatory factors and myeloid‐derived suppressor cells indicate poor prognosis in advanced melanoma patients
  Huanhuan Jiang, Christoffer Gebhardt, Ludmila Umansky, Philipp Beckhove, Torsten J. Schulze, Jochen Utikal, Viktor Umansky
  International Journal of Cancer.2015; 136(10): 2352.     CrossRef
• The Clinical Research of Serum VEGF, TGF-β1, and Endostatin in Non-small Cell Lung Cancer
  Shu-Guang Liu, Shuang-Hu Yuan, Hui-Yong Wu, Jie Liu, Cheng-Suo Huang
  Cell Biochemistry and Biophysics.2015; 72(1): 165.     CrossRef
• Platelet VEGF and serum TGF-β1 levels predict chemotherapy response in non-small cell lung cancer patients
  Bao-Hong Fu, Zhan-Zhao Fu, Wei Meng, Tao Gu, Xiao-Dong Sun, Zhi Zhang
  Tumor Biology.2015; 36(8): 6477.     CrossRef
• Pulmonary Large-Cell Neuroendocrine Carcinoma: From Epidemiology to Therapy
  Morena Fasano, Carminia Maria Della Corte, Federica Papaccio, Fortunato Ciardiello, Floriana Morgillo
  Journal of Thoracic Oncology.2015; 10(8): 1133.     CrossRef
• The angiogenic responses induced by release of angiogenic proteins from tumor cell‐activated platelets are regulated by distinct molecular pathways
  Hongyan Wu, Fangtian Fan, Zhaoguo Liu, Feng Zhang, Yuping Liu, Zhonghong Wei, Cunsi Shen, Yuzhu Cao, Aiyun Wang, Yin Lu
  IUBMB Life.2015; 67(8): 626.     CrossRef
• Serum Calprotectin, CD26 and EGF to Establish a Panel for the Diagnosis of Lung Cancer
  Sonia Blanco-Prieto, Lorena Vázquez-Iglesias, Mar Rodríguez-Girondo, Leticia Barcia-Castro, Alberto Fernández-Villar, María Isabel Botana-Rial, Francisco Javier Rodríguez-Berrocal, María Páez de la Cadena, Rossella Rota
  PLOS ONE.2015; 10(5): e0127318.     CrossRef